{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:08:45Z","timestamp":1786763325557,"version":"build-2736575974"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1038\/s41375-025-02607-5","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T11:05:52Z","timestamp":1745319952000},"page":"1368-1379","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Loss of NOL10 leads to impaired disease progression of NUP98::DDX10 leukemia"],"prefix":"10.1038","volume":"39","author":[{"given":"Yutaka","family":"Shima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutsune","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kuroki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8409-0407","authenticated-orcid":false,"given":"Issay","family":"Kitabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"2607_CR1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nrm2928","volume":"11","author":"C Strambio-De-Castillia","year":"2010","unstructured":"Strambio-De-Castillia C, Niepel M, Rout MP. The nuclear pore complex: bridging nuclear transport and gene regulation. Nat Rev Mol Cell Biol. 2010;11:490\u2013501.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2607_CR2","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ng0296-154","volume":"12","author":"T Nakamura","year":"1996","unstructured":"Nakamura T, Largaespada D, Lee M, Johnson L, Ohyashiki K, Toyama K, et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet. 1996;12:154\u20138.","journal-title":"Nat Genet"},{"key":"2607_CR3","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1182\/blood.V99.7.2526","volume":"99","author":"J Brown","year":"2002","unstructured":"Brown J, Jawad M, Twigg SRF, Saracoglu K, Sauerbrey A, Thomas AE, et al. A cryptic t(5;11)(q35;p15.5) in 2 children with acute myeloid leukemia with apparently normal karyotypes, identified by a multiplex fluorescence in situ hybridization telomere assay. Blood. 2002;99:2526\u201331.","journal-title":"Blood"},{"key":"2607_CR4","doi-asserted-by":"publisher","first-page":"3936","DOI":"10.1182\/blood.V89.11.3936","volume":"89","author":"Y Arai","year":"1997","unstructured":"Arai Y, Hosoda F, Kobayashi H, Arai K, Hayashi Y, Kamada N, et al. The inv(11)(p15q22) chromosome translocation of de novo and therapy- related myeloid malignancies results in fusion of the nucleoporin gene, NUP98, with the putative RNA helicase gene, DDX10. Blood. 1997;89:3936\u201344.","journal-title":"Blood"},{"key":"2607_CR5","doi-asserted-by":"publisher","first-page":"6247","DOI":"10.1182\/blood-2011-07-328880","volume":"118","author":"SM Gough","year":"2011","unstructured":"Gough SM, Slape CI, Aplan PD. NUP98 gene fusions and hematopoietic malignancies: Common themes and new biologic insights. Blood. 2011;118:6247\u201357.","journal-title":"Blood"},{"key":"2607_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41586-021-03662-5","volume":"595","author":"JH Ahn","year":"2021","unstructured":"Ahn JH, Davis ES, Daugird TA, Zhao S, Quiroga IY, Uryu H, et al. Phase separation drives aberrant chromatin looping and cancer development. Nature. 2021;595:591\u20135.","journal-title":"Nature"},{"key":"2607_CR7","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ccell.2016.10.019","volume":"30","author":"H Xu","year":"2016","unstructured":"Xu H, Valerio DG, Eisold ME, Sinha A, Koche RP, Hu W, et al. NUP98 fusion proteins interact with the NSL and MLL1 complexes to drive leukemogenesis. Cancer Cell. 2016;30:863\u201378.","journal-title":"Cancer Cell"},{"key":"2607_CR8","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/leu.2017.62","volume":"31","author":"Y Shima","year":"2017","unstructured":"Shima Y, Yumoto M, Katsumoto T, Kitabayashi I. MLL is essential for NUP98-HOXA9-induced leukemia. Leukemia. 2017;31:2200\u201310.","journal-title":"Leukemia"},{"key":"2607_CR9","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/ncb1608","volume":"9","author":"GG Wang","year":"2007","unstructured":"Wang GG, Cai L, Pasillas MP, Kamps MP. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis. Nat Cell Biol. 2007;9:804\u201312.","journal-title":"Nat Cell Biol"},{"key":"2607_CR10","doi-asserted-by":"publisher","first-page":"9803","DOI":"10.1093\/nar\/gkw790","volume":"44","author":"L Bammert","year":"2016","unstructured":"Bammert L, Jonas S, Ungricht R, Kutay U. Human AATF\/Che-1 forms a nucleolar protein complex with NGDN and NOL10 required for 40S ribosomal subunit synthesis. Nucleic Acids Res. 2016;44:9803\u201320.","journal-title":"Nucleic Acids Res"},{"key":"2607_CR11","first-page":"1","volume":"14","author":"X Jin","year":"2023","unstructured":"Jin X, Tanaka H, Jin M, Fujita K, Homma H, Inotsume M, et al. PQBP5\/NOL10 maintains and anchors the nucleolus under physiological and osmotic stress conditions. Nat Commun. 2023;14:1\u20135.","journal-title":"Nat Commun"},{"key":"2607_CR12","doi-asserted-by":"publisher","first-page":"4278","DOI":"10.1158\/0008-5472.CAN-12-3814","volume":"73","author":"Y Shima","year":"2013","unstructured":"Shima Y, Honma Y, Kitabayashi I. PML-RAR\u03b1 and its phosphorylation regulate PML oligomerization and HIPK2 stability. Cancer Res. 2013;73:4278\u201388.","journal-title":"Cancer Res"},{"key":"2607_CR13","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1091\/mbc.e09-07-0561","volume":"21","author":"S Xu","year":"2010","unstructured":"Xu S, Powers MA. Nup98-homeodomain fusions interact with endogenous Nup98 during interphase and localize to kinetochores and chromosome arms during mitosis. Mol Biol Cell. 2010;21:1585\u201396.","journal-title":"Mol Biol Cell"},{"key":"2607_CR14","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1182\/blood.2019003267","volume":"136","author":"J Schmoellerl","year":"2020","unstructured":"Schmoellerl J, Barbosa IAM, Eder T, Brandstoetter T, Schmidt L, Maurer B, et al. CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia. Blood. 2020;136:387\u2013400.","journal-title":"Blood"},{"key":"2607_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-022-02248-x","volume":"41","author":"Z Jevtic","year":"2022","unstructured":"Jevtic Z, Matafora V, Casagrande C, Santoro F, Minucci S, Garr\u00e9 M, et al. SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation. J Exp Clin Cancer Res. 2022;41:34.","journal-title":"J Exp Clin Cancer Res"},{"key":"2607_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41594-020-00550-w","volume":"28","author":"S Terlecki-Zaniewicz","year":"2021","unstructured":"Terlecki-Zaniewicz S, Humer T, Eder T, Schmoellerl J, Heyes E, Manhart G, et al. Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression. Nat Struc Mol Biol. 2021;28:190\u2013201.","journal-title":"Nat Struc Mol Biol"},{"key":"2607_CR17","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1038\/ng.3421","volume":"47","author":"GM DeNicola","year":"2015","unstructured":"DeNicola GM, Chen PH, Mullarky E, Sudderth JA, Hu Z, Wu D, et al. NRF2 regulates serine biosynthesis in non-small cell lung cancer. Nat Genet. 2015;47:1475\u201381.","journal-title":"Nat Genet"},{"key":"2607_CR18","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrc.2016.81","volume":"16","author":"M Yang","year":"2016","unstructured":"Yang M, Vousden KH. Serine and one-carbon metabolism in cancer. Nat Rev Cancer. 2016;16:650\u201362.","journal-title":"Nat Rev Cancer"},{"key":"2607_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1083\/jcb.201604085","volume":"214","author":"KR Mattaini","year":"2016","unstructured":"Mattaini KR, Sullivan MR, Vander Heiden MG. The importance of serine metabolism in cancer. J Cell Biol. 2016;214:249\u201357.","journal-title":"J Cell Biol"},{"key":"2607_CR20","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41392-021-00678-1","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Zhang L, Dai T, Qin Z, Lu H, Zhang L, et al. Liquid\u2013liquid phase separation in human health and diseases. Signal Transduct Target Ther. 2021;6:290.","journal-title":"Signal Transduct Target Ther"},{"key":"2607_CR21","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2018.10.042","volume":"175","author":"A Boija","year":"2018","unstructured":"Boija A, Klein IA, Sabari BR, Dall\u2019Agnese A, Coffey EL, Zamudio AV, et al. Transcription factors activate genes through the phase-separation capacity of their activation domains. Cell. 2018;175:1842\u201355.","journal-title":"Cell"},{"key":"2607_CR22","doi-asserted-by":"publisher","first-page":"7223","DOI":"10.1038\/sj.onc.1204765","volume":"20","author":"K Jensen","year":"2001","unstructured":"Jensen K, Shiels C, Freemont PS. PML protein isoforms and the RBCC\/TRIM motif. Oncogene. 2001;20:7223\u201333.","journal-title":"Oncogene"},{"key":"2607_CR23","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1038\/sj.onc.1207533","volume":"23","author":"Y Takahashi","year":"2004","unstructured":"Takahashi Y, Lallemand-Breitenbach V, Zhu J, de Th\u00e9 H. PML nuclear bodies and apoptosis. Oncogene. 2004;23:2819\u201324.","journal-title":"Oncogene"},{"key":"2607_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1182\/blood-2004-03-1185","volume":"105","author":"LA Nguyen","year":"2005","unstructured":"Nguyen LA, Pandolfi PP, Aikawa Y, Tagata Y, Ohki M, Kitabayashi I. Physical and functional link of the leukemia-associated factors AML1 and PML. Blood. 2005;105:292\u2013300.","journal-title":"Blood"},{"key":"2607_CR25","first-page":"2917","volume":"30","author":"JL Davis","year":"1970","unstructured":"Davis JL, Fallon HJ, Morris HP. Two enzymes of serine metabolism in rat liver and hepatomas. Cancer Res. 1970;30:2917\u201320.","journal-title":"Cancer Res"},{"key":"2607_CR26","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0065-2571(84)90021-9","volume":"22","author":"K Snell","year":"1984","unstructured":"Snell K. Enzymes of serine metabolism in normal, developing and neoplastic rat tissues. Adv Enzym Regul. 1984;22:325\u2013400.","journal-title":"Adv Enzym Regul"},{"key":"2607_CR27","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s10549-010-0848-5","volume":"125","author":"S Pollari","year":"2011","unstructured":"Pollari S, K\u00e4k\u00f6nen SM, Edgren H, Wolf M, Kohonen P, Sara H, et al. Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis. Breast Cancer Res Treat. 2011;125:421\u201330.","journal-title":"Breast Cancer Res Treat"},{"key":"2607_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11060-012-1018-x","volume":"111","author":"J Liu","year":"2013","unstructured":"Liu J, Guo S, Li Q, Yang L, Xia Z, Zhang L, et al. Phosphoglycerate dehydrogenase induces glioma cells proliferation and invasion by stabilizing forkhead box M1. J Neurooncol. 2013;111:245\u201355.","journal-title":"J Neurooncol"},{"key":"2607_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-20223-y","volume":"12","author":"M Tajan","year":"2021","unstructured":"Tajan M, Hennequart M, Cheung EC, Zani F, Hock AK, Legrave N, et al. Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy. Nat Commun. 2021;12:1\u201316.","journal-title":"Nat Commun"},{"key":"2607_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0014-4827(78)90070-8","volume":"116","author":"RW Allen","year":"1978","unstructured":"Allen RW, Moskowitz M. Arrest of cell growth in the G1 phase of the cell cycle by serine deprivation. Exp Cell Res. 1978;116:127\u201337.","journal-title":"Exp Cell Res"},{"key":"2607_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0003-9861(85)90627-7","volume":"236","author":"PB Rowe","year":"1985","unstructured":"Rowe PB, Sauer D, Fahey D, Craig G, McCairns E. One-carbon metabolism in lectin-activated human lymphocytes. Arch Biochem Biophys. 1985;236:277\u201388.","journal-title":"Arch Biochem Biophys"},{"key":"2607_CR32","doi-asserted-by":"crossref","unstructured":"Davis SR, Stacpoole PW, Williamson J, Kick LS, Quinlivan EP, Coats BS, et al. Tracer-derived total and folate-dependent homocysteine remethylation and synthesis rates in humans indicate that serine is the main one-carbon donor. Am J Physiol Endocrinol Metab. 2004;286:272\u20139.","DOI":"10.1152\/ajpendo.00351.2003"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02607-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02607-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02607-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:04:34Z","timestamp":1748934274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-025-02607-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["2607"],"URL":"https:\/\/doi.org\/10.1038\/s41375-025-02607-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3896248\/v1","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"25 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}